20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Angiogenesis, Pathologic in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Azcona, JA; Berry, E; Falck, JR; Garvey, R; Guo, AM; Jeitner, TM; Schwartzman, ML; Tang, S; Yi, T; Zhang, FF | 1 |
| Chen, H; Chen, X; Duan, C; Li, Y; Liu, Y; Qin, T; Wang, C; Yang, J; Zhang, J; Zhou, X | 1 |
| Rocic, P; Schwartzman, ML | 1 |
| Cheng, G; Li, J; Li, Y; Li, Z; Liu, Y; Lu, L; Teng, G; Zhan, M | 1 |
| Ackerman, R; Chen, L; Guo, AM | 1 |
| Grant, MB; Ljubimov, AV | 1 |
| Chen, P; Edwards, PA; Falck, JR; Guo, M; Roman, RJ; Scicli, AG; Wygle, D | 1 |
2 review(s) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Angiogenesis, Pathologic
| Article | Year |
|---|---|
20-HETE in the regulation of vascular and cardiac function.
Topics: Animals; Cardiovascular Diseases; Endothelium, Vascular; ErbB Receptors; Humans; Hydroxyeicosatetraenoic Acids; Neovascularization, Pathologic; Neovascularization, Physiologic; Obesity; Receptors, G-Protein-Coupled; Signal Transduction; Vascular Remodeling | 2018 |
20-HETE in neovascularization.
Topics: Animals; Cytochrome P-450 CYP4A; Endothelial Cells; Humans; Hydroxyeicosatetraenoic Acids; Neovascularization, Pathologic; Neovascularization, Physiologic; Signal Transduction | 2012 |
5 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Neutrophil-Derived Myeloperoxidase and Hypochlorous Acid Critically Contribute to 20-Hydroxyeicosatetraenoic Acid Increases that Drive Postischemic Angiogenesis.
Topics: Animals; Endothelial Cells; Hydroxyeicosatetraenoic Acids; Hypochlorous Acid; Ischemia; Mice; Neovascularization, Pathologic; Neutrophils; Peroxidase | 2022 |
Inhibition of CYP4A by a novel flavonoid FLA-16 prolongs survival and normalizes tumor vasculature in glioma.
Topics: Angiogenesis Inhibitors; Animals; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chalcones; Culture Media, Conditioned; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Endothelial Progenitor Cells; Flavonoids; Glioma; Humans; Hydroxyeicosatetraenoic Acids; Macrophages; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Neovascularization, Pathologic; Paracrine Communication; Pericytes; Rats, Wistar; Time Factors; Transforming Growth Factor beta; Tumor Burden; Tumor Microenvironment; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2017 |
Astrocytic cytochrome P450 4A/20-hydroxyeicosatetraenoic acid contributes to angiogenesis in the experimental ischemic stroke.
Topics: Angiogenesis Inducing Agents; Animals; Astrocytes; Brain Ischemia; Cell Proliferation; Cytochrome P-450 CYP4A; Disease Models, Animal; Endothelial Cells; Hydroxyeicosatetraenoic Acids; Male; Mice; Mice, Inbred C57BL; Microcirculation; Neovascularization, Pathologic; Stroke; Vascular Endothelial Growth Factor A | 2019 |
P450 in the angiogenesis affair: the unusual suspect.
Topics: Animals; Cytochrome P-450 Enzyme System; Growth Substances; Humans; Hydroxyeicosatetraenoic Acids; Neovascularization, Pathologic | 2005 |
Inhibitors of cytochrome P450 4A suppress angiogenic responses.
Topics: Amides; Amidines; Animals; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Cornea; Cytochrome P-450 CYP4A; DNA, Complementary; Endothelium, Vascular; Enzyme Inhibitors; Fibroblast Growth Factor 2; Humans; Hydroxyeicosatetraenoic Acids; Male; Mitogens; Neovascularization, Pathologic; Polymerase Chain Reaction; Polymers; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sulfones; Umbilical Veins; Vascular Endothelial Growth Factor A | 2005 |